Skip to main content
Caplight Logo









CereGate

CereGate

Private
MunichHealthcare & Life Scienceshttps://www.ceregate.com/

Last Round

VC Round

Jan 12, 2022

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CereGate is a healthtech company that develops a hardware-agnostic computer-brain interface software platform to enhance neuromodulation therapies for neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

computer-brain interfaceCBIbrain-computer interfaceBCIneuromodulationneurotechnologydeep brain stimulationDBSspinal cord stimulationSCSmedical device softwareadaptive therapyneuro-AImovement disorder treatmentclinical trial support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CereGate Comparables

Compare CereGate with similar companies based on industry and business-model similarity.

CereGate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bitfinex
74%
BIOS Health
69%
CorTec
67%

CereGate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 12, 2022
Series ASep 3, 2020
SeedJan 23, 2020

Key People

Founding team and executive leadership

Matthias Puls

CEO & Managing Director

Executive Team

CereGate Investors

Notable investors and investment history

CereGate investors
InvestorRounds
TruVenturoSeries A, VC Round, Seed
re.Mind CapitalVC Round
CARMA FUNDVC Round
High-Tech GründerfondsSeries A, VC Round, Seed
468 CapitalVC Round
Heal CapitalVC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 400% MoM.

  • May 17, 2026

    Monthly visitors increased 1789% MoM, from 35 to 661.

CereGate Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CereGate Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CereGate's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range15
Year Founded2019
Last FundingJan 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?